A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

The province is expanding a program to provide innovative preventive surgery for those at risk of ovarian cancer ...

AOA Dx debuted Follow the Exits at JPM 2026, analyzing 25 years of women’s health exits—$100B+ in value—proving a ...

Mid and South Essex NHS Foundation Trust figures show that at the end of August, 664 patients were waiting longer than 62 ...

Kara Tointon has spoken out after undergoing a double mastectomy following a genetic test. The former EastEnders star, who ...

Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of protein drugs known as DARPin therapeutics ...

The former EastEnders actress, 41, revealed that she had surgery to remove both of her breasts, as well as her fallopian ...

Full-body MRI scans are gaining popularity, but doctors warn their benefits may not outweigh the risks for healthy, ...

The third-line results build on equally compelling second-line data, where pelareorep achieved a 30% response rate, more than doubling the 13.8% benchmark for the only FDA-approved immunotherapy in ...

Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...

Mirador Therapeutics, Inc. (Mirador), a clinical-stage precision medicine company developing next-generation therapies for immune-mediated inflammatory and fibrotic diseases, today announced key ...

GeneDx Holdings Corp. , a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for the fourth quarter and full year of 2025. "In 2025, ...